Asset Details
Do you wish to reserve the book?
In Vitro Human Cell Line Models to Predict Clinical Response to Anticancer Drugs
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
In Vitro Human Cell Line Models to Predict Clinical Response to Anticancer Drugs
Do you wish to request the book?
In Vitro Human Cell Line Models to Predict Clinical Response to Anticancer Drugs
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
In Vitro Human Cell Line Models to Predict Clinical Response to Anticancer Drugs
2015
Overview
In vitro human cell line models have been widely used for cancer pharmacogenomic studies to predict clinical response, to help generate pharmacogenomic hypothesis for further testing, and to help identify novel mechanisms associated with variation in drug response. Among cell line model systems, immortalized cell lines such as Epstein-Barr virus (EBV)-transformed lymphoblastoid cell lines (LCLs) have been used most often to test the effect of germline genetic variation on drug efficacy and toxicity. Another model, especially in cancer research, uses cancer cell lines such as the NCI-60 panel. These models have been used mainly to determine the effect of somatic alterations on response to anticancer therapy. Even though these cell line model systems are very useful for initial screening, results from integrated analyses of multiple omics data and drug response phenotypes using cell line model systems still need to be confirmed by functional validation and mechanistic studies, as well as validation studies using clinical samples. Future models might include the use of patient-specific inducible pluripotent stem cells and the incorporation of 3D culture which could further optimize in vitro cell line models to improve their predictive validity.
Publisher
Future Medicine Ltd
Subject
Antineoplastic Agents - therapeutic use
/ Breast Neoplasms - drug therapy
/ Cell Line, Transformed - drug effects
/ Cell Line, Transformed - virology
/ Cell Line, Tumor - drug effects
/ Colorectal Neoplasms - drug therapy
/ Colorectal Neoplasms - genetics
/ Drug Screening Assays, Antitumor - methods
/ Female
/ Humans
/ Induced Pluripotent Stem Cells - drug effects
